alimera
sciences
report
third
quarter
financial
results
wednesday
october
provide
corporate
update
atlanta
globe
newswire
alimera
sciences
nasdaq
alim
alimera
company
leader
commercialization
development
prescription
ophthalmology
treatments
management
retinal
diseases
announces
today
report
third
quarter
financial
results
wednesday
october
market
close
management
host
conference
call
et
thursday
october
review
financial
results
provide
update
corporate
developments
following
management
formal
remarks
question
answer
session
participants
asked
call
please
note
registered
participants
receive
number
upon
registration
dial
directly
call
without
delay
without
internet
access
unable
may
dial
calling
domestic
international
callers
dial
approximately
minutes
prior
scheduled
start
time
ask
joined
alimera
sciences
call
conference
call
also
available
live
webcast
also
available
company
website
webcast
replay
call
available
approximately
one
hour
end
call
january
webcast
replay
accessed
links
calling
domestic
international
using
access
code
telephonic
replay
available
november
alimera
sciences
alimera
sciences
pharmaceutical
company
specializes
commercialization
development
prescription
ophthalmic
pharmaceuticals
alimera
presently
focused
diseases
affecting
back
eye
retina
diseases
well
treated
current
therapies
affect
millions
people
aging
populations
information
please
visit
